Cart 0 $0.00
IRE favicon


Resource ID: #26757
Subject: Drugs
Source: Milwaukee Journal Sentinel
Date: 2014-12-22



These stories examined how the FDA approved cancer and diabetes drugs over the last decade. It found that in 74% of cancer drug approvals and all diabetes drug approvals, the decision to allow the drugs on the market was based on surrogate measures of effectiveness such CT scans or blood tests rather than real clinical outcomes such as improved survival or reductions in heart attacks, strokes or blindness.

109 Lee Hills Hall, Missouri School of Journalism   |   221 S. Eighth St., Columbia, MO 65201   |   573-882-2042   |   |   Privacy Policy
apartmentpenciluserscalendar-fullcrossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram
My cart
Your cart is empty.

Looks like you haven't made a choice yet.